$HTLD
HEARTLAND EXPRESS INC Stock $htld

$htld Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000079923324000020 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$274.8M	$270.3M
YoY Change	-10.26%	-18.31%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$216.0M	$222.5M
YoY Change	-7.38%	-10.45%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$46.14M	$46.50M
YoY Change	-4.55%	-4.05%
% of Gross Profit
Operating Expenses	$275.6M	$284.6M
YoY Change	-7.5%	-9.59%
Operating Profit	$264.0K	-$14.38M
YoY Change	-98.37%	-162.84%
Interest Expense	-$4.286M	-$4.936M
YoY Change	-22.34%	-181.25%
% of Operating Profit	-1623.48%
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.022M	-$19.32M
YoY Change	-137.55%	-211.68%
Income Tax	-$544.0K	-$4.211M
% Of Pretax Income
Net Earnings	-$3.478M	-$15.11M
YoY Change	-144.76%	-219.79%
Net Earnings / Revenue	-1.27%	-5.59%
Basic Earnings Per Share	-$0.04	-$0.19
Diluted Earnings Per Share	-$0.04	-$0.19
COMMON SHARES
Basic Shares Outstanding	79.05M shares	79.05M shares
Diluted Shares Outstanding	78.98M shares	79.12M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.86M	$23.82M
YoY Change	-48.41%	-57.08%
Cash & Equivalents	$23.86M	$23.82M
Short-Term Investments
Other Short-Term Assets	$26.67M	$23.26M
YoY Change	-11.46%	17.62%
Inventory
Prepaid Expenses
Receivables	$108.9M	$107.9M
Other Receivables	$4.678M	$5.128M
Total Short-Term Assets	$164.1M	$160.1M
YoY Change	-17.43%	-24.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$814.2M	$855.6M
YoY Change	-13.53%	-8.82%
Goodwill	$322.6M	$322.6M
YoY Change	0.6%	0.6%
Intangibles	$96.03M	$97.28M
YoY Change	-5.02%	-5.01%
Long-Term Investments
YoY Change
Other Assets	$16.46M	$16.87M
YoY Change	-52.32%	-14.12%
Total Long-Term Assets	$1.249B	$1.292B
YoY Change	-10.63%	-7.7%
TOTAL ASSETS
Total Short-Term Assets	$164.1M	$160.1M
Total Long-Term Assets	$1.249B	$1.292B
Total Assets	$1.413B	$1.452B
YoY Change	-11.48%	-9.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$40.02M	$35.70M
YoY Change	-34.45%	-24.82%
Accrued Expenses	$85.18M	$82.78M
YoY Change	14.64%	8.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.644M	$8.986M
YoY Change	-31.38%	-32.47%
Total Short-Term Liabilities	$133.8M	$127.5M
YoY Change	-9.54%	-13.03%
LONG-TERM LIABILITIES
Long-Term Debt	$228.5M	$254.6M
YoY Change	-32.02%	-27.8%
Other Long-Term Liabilities	$41.11M	$41.76M
YoY Change	-9.03%	-12.19%
Total Long-Term Liabilities	$269.6M	$296.4M
YoY Change	-29.3%	-50.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$133.8M	$127.5M
Total Long-Term Liabilities	$269.6M	$296.4M
Total Liabilities	$576.7M	$603.7M
YoY Change	-20.32%	-19.06%
SHAREHOLDERS EQUITY
Retained Earnings	$1.038B	$1.043B
YoY Change	-2.85%	-1.81%
Common Stock	$5.240M	$5.425M
YoY Change	9.05%	6.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$206.8M	$200.0M
YoY Change	3.04%	-0.56%
Treasury Stock Shares
Shareholders Equity	$836.8M	$848.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.413B	$1.452B
YoY Change	-11.48%	-9.92%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$3.478M	-$15.11M
YoY Change	-144.76%	-219.79%
Depreciation, Depletion And Amortization	$46.14M	$46.50M
YoY Change	-4.55%	-4.05%
Cash From Operating Activities	$39.99M	$30.98M
YoY Change	29.78%	-53.38%
INVESTING ACTIVITIES
Capital Expenditures	$10.55M	$4.697M
YoY Change	-83.99%	-88.86%
Acquisitions
YoY Change
Other Investing Activities	$5.964M	$0.00
YoY Change	-86.72%	-100.0%
Cash From Investing Activities	-$4.583M	$1.952M
YoY Change	-78.13%	-115.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.66M	-$36.72M
YoY Change	86.26%	-22.47%
NET CHANGE
Cash From Operating Activities	39.99M	$30.98M
Cash From Investing Activities	-4.583M	$1.952M
Cash From Financing Activities	-35.66M	-$36.72M
Net Change In Cash	-249.0K	-$3.795M
YoY Change	-97.32%	-160.48%
FREE CASH FLOW
Cash From Operating Activities	$39.99M	$30.98M
Capital Expenditures	$10.55M	$4.697M
Free Cash Flow	$29.44M	$26.28M
YoY Change	-183.99%	8.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.02
CY2023Q1	htld	Restricted Cash And Investments Current Total RestrictedCashAndInvestmentsCurrentTotal	700000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	14500000	usd
CY2024Q1	htld	Restricted Stock Shares Remaining Available RestrictedStockSharesRemainingAvailable	455992	shares
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	100000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.218	rate
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.271	rate
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	112697000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	123333000	usd
CY2024Q1	htld	Rent And Purchased Transportation RentAndPurchasedTransportation	23863000	usd
CY2023Q1	htld	Rent And Purchased Transportation RentAndPurchasedTransportation	33144000	usd
CY2024Q1	us-gaap	Fuel Costs FuelCosts	47321000	usd
CY2023Q1	us-gaap	Fuel Costs FuelCosts	57528000	usd
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	16264000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	15026000	usd
CY2024Q1	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	5315000	usd
CY2023Q1	us-gaap	Direct Taxes And Licenses Costs DirectTaxesAndLicensesCosts	5543000	usd
CY2024Q1	us-gaap	Operating Insurance And Claims Costs Production OperatingInsuranceAndClaimsCostsProduction	14584000	usd
CY2023Q1	us-gaap	Operating Insurance And Claims Costs Production OperatingInsuranceAndClaimsCostsProduction	11002000	usd
CY2024Q1	us-gaap	Direct Communications And Utilities Costs DirectCommunicationsAndUtilitiesCosts	2440000	usd
CY2023Q1	us-gaap	Direct Communications And Utilities Costs DirectCommunicationsAndUtilitiesCosts	2876000	usd
CY2024Q1	htld	Depreciationandamortizationexcludingdepreciationoncommunicationequipment Depreciationandamortizationexcludingdepreciationoncommunicationequipment	46504000	usd
CY2023Q1	htld	Depreciationandamortizationexcludingdepreciationoncommunicationequipment Depreciationandamortizationexcludingdepreciationoncommunicationequipment	48469000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	15626000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	17891000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-89000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6786000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	284703000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	308026000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14383000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	22890000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	366000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	484000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	5302000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	6075000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19319000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17299000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4211000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4687000	usd
CY2024Q1	htld	Net Income NetIncome	-15108000	usd
CY2023Q1	htld	Net Income NetIncome	12612000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15108000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12612000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79044000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78987000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79122000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79022000	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.02
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.02
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	865260000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15108000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1582000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	220000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	848790000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	855477000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	12612000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1581000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	111000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	866619000	usd
CY2024Q1	htld	Net Income2 NetIncome2	-15108000	usd
CY2023Q1	htld	Net Income2 NetIncome2	12612000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46504000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48469000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	9178000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	8659000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	283000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	152000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	263000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	269000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-89000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6786000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5192000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-13649000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2586000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4864000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5732000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10978000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4997000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	12850000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30976000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	66442000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6649000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	28859000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4697000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42149000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-489000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1952000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12801000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	63000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	41000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	36660000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	47325000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-36723000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47366000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3795000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6275000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41188000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64478000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37393000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70753000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	5289000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6121000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-77000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	232000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4812000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2059000	usd
CY2024Q1	htld	Soldrevenueequipmentinothercurrentassets Soldrevenueequipmentinothercurrentassets	0	usd
CY2023Q1	htld	Soldrevenueequipmentinothercurrentassets Soldrevenueequipmentinothercurrentassets	232000	usd
CY2024Q1	htld	Common Stock Dividends Declared In Accounts Payable CommonStockDividendsDeclaredInAccountsPayable	1582000	usd
CY2023Q1	htld	Common Stock Dividends Declared In Accounts Payable CommonStockDividendsDeclaredInAccountsPayable	1581000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23823000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55506000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	323000	usd
CY2023Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	746000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	13247000	usd
CY2023Q1	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	14501000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37393000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70753000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segments
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1900000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1900000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Revenues Revenues	270300000	usd
CY2023Q1	us-gaap	Revenues Revenues	330900000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	20100000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24600000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13500000	usd
CY2024Q1	htld	Restricted Cash And Investments Current Total RestrictedCashAndInvestmentsCurrentTotal	300000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	13200000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13000000	usd
CY2023Q4	htld	Restricted Cash And Investments Current Total RestrictedCashAndInvestmentsCurrentTotal	300000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	12700000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	htld	Amortization Period Of Tires AmortizationPeriodOfTires	two years
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	htld	Increase Decrease Of Restricted Cash And Investments IncreaseDecreaseOfRestrictedCashAndInvestments	0	usd
CY2023	htld	Increase Decrease Of Restricted Cash And Investments IncreaseDecreaseOfRestrictedCashAndInvestments	2500000	usd
CY2024Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2024Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	97300000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	31600000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65700000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	94575000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28916000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65659000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	322600000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	htld	Net Income Loss Eps NetIncomeLossEPS	-15108000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79044000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	78000	shares
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15108000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79122000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q1	htld	Net Income Loss Eps NetIncomeLossEPS	12612000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78987000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	35000	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12612000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79022000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2024Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	6600000	shares
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1600000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1600000	usd
CY2011Q3	htld	Restricted Stock Shares Authorized RestrictedStockSharesAuthorized	900000	shares
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2021Q2	htld	Restricted Stock Shares Authorized RestrictedStockSharesAuthorized	600000	shares
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	200000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	200000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y4M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	85800	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	5000.0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.65
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	17000.0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	14.67
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	73800	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.67
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	40100	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	16.01
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	7000.0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	15.95
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	33100	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	16.02
CY2022Q3	htld	Unsecured Credit Facility UnsecuredCreditFacility	550000000	usd
CY2022Q3	htld	Revolving Facility RevolvingFacility	100000000	usd
CY2022Q3	htld	Term Facility TermFacility	450000000	usd
CY2022Q3	htld	Revolving Facility RevolvingFacility	100000000	usd
CY2022Q3	htld	Available Issuance Of Line Of Credit AvailableIssuanceOfLineOfCredit	50000000	usd
CY2022Q3	htld	Swingline Facility SwinglineFacility	20000000	usd
CY2022Q3	htld	Uncommitted Accordion Feature UncommittedAccordionFeature	275000000	usd
CY2024Q1	htld	Max Annual Dividend MaxAnnualDividend	10000000	usd
CY2024Q1	htld	Debt Instrument Covenant Distributions Max Leverage Ratio DebtInstrumentCovenantDistributionsMaxLeverageRatio	2.5
CY2024Q1	htld	Debt Instrument Covenant Maximum Net Leverage Ratio DebtInstrumentCovenantMaximumNetLeverageRatio	2.75
CY2024Q1	htld	Debt Instrument Covenant Minimum Interest Coverage Ratio DebtInstrumentCovenantMinimumInterestCoverageRatio	3
CY2024Q1	htld	Term Sofr One Month Spread TermSOFROneMonthSpread	0.011	rate
CY2024Q1	htld	Applicable Margin Base ApplicableMarginBase	0.0100	rate
CY2024Q1	htld	Outstanding Debt On Term Facility OutstandingDebtOnTermFacility	240000000	usd
CY2024Q1	htld	Outstanding Debt On Revolving Facility OutstandingDebtOnRevolvingFacility	0	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	12000000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	88000000	usd
CY2024Q1	htld	Weighted Average Interest Rate Credit Facility WeightedAverageInterestRateCreditFacility	0.070	rate
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	1000000	usd
CY2022Q2	htld	Business Combination Long Term Debt BusinessCombinationLongTermDebt	46800000	usd
CY2024Q1	htld	Business Combination Long Term Debt BusinessCombinationLongTermDebt	24600000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	htld	Debt Debt	7300000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.044	rate
CY2024Q1	htld	Finance Lease Obligations FinanceLeaseObligations	17300000	usd
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.039	rate
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q4	htld	Gain On Sale Of Properties GainOnSaleOfProperties	25600000	usd
CY2024Q1	htld	Right Of Use Asset Associated With The Leased Terminal Facilities RightOfUseAssetAssociatedWithTheLeasedTerminalFacilities	7700000	usd
CY2024Q1	htld	Right Of Use Operating Lease Assets RightOfUseOperatingLeaseAssets	6400000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055	rate
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6457000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	6773000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6609000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	7557000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1587000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	3840000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	320000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14973000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	18170000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	829000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	836000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	14144000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	17334000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7740000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7216000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6404000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	10118000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5500000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5500000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4400000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	100000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-100000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	800000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	800000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	700000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5522000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	66000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5456000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	4800000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000799233-24-000020-index-headers.html	Edgar Link	pending
0000799233-24-000020-index.html	Edgar Link	pending
0000799233-24-000020.txt	Edgar Link	pending
0000799233-24-000020-xbrl.zip	Edgar Link	pending
exhibit3112024q1.htm	Edgar Link	pending
exhibit3122024q1.htm	Edgar Link	pending
exhibit3212024q1.htm	Edgar Link	pending
exhibit3222024q1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htld-20240331.htm	Edgar Link	pending
htld-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
htld-20240331_cal.xml	Edgar Link	unprocessable
htld-20240331_def.xml	Edgar Link	unprocessable
htld-20240331_lab.xml	Edgar Link	unprocessable
htld-20240331_pre.xml	Edgar Link	unprocessable
htld-20240331_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HTLD
HEARTLAND EXPRESS INC Stock $htld

2024 Q2 Form 10-Q Financial Statement

#000079923324000020 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HTLD HEARTLAND EXPRESS INC Stock $htld

2024 Q2 Form 10-Q Financial Statement

#000079923324000020 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HTLD
HEARTLAND EXPRESS INC Stock $htld